Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Vessel Prosthesis Implantation | 8 | 2023 | 239 | 1.940 |
Why?
|
| Endarterectomy, Carotid | 3 | 2023 | 76 | 1.520 |
Why?
|
| Endovascular Procedures | 6 | 2023 | 334 | 1.470 |
Why?
|
| Aortic Aneurysm, Abdominal | 4 | 2023 | 121 | 1.070 |
Why?
|
| Blood Vessel Prosthesis | 5 | 2023 | 248 | 1.050 |
Why?
|
| Carotid Stenosis | 3 | 2023 | 115 | 1.030 |
Why?
|
| Ischemic Attack, Transient | 2 | 2023 | 188 | 0.850 |
Why?
|
| Stents | 6 | 2023 | 422 | 0.840 |
Why?
|
| Hospital Costs | 3 | 2023 | 117 | 0.830 |
Why?
|
| Stroke | 4 | 2023 | 1089 | 0.830 |
Why?
|
| Medicare | 3 | 2023 | 458 | 0.790 |
Why?
|
| Aneurysm | 2 | 2020 | 61 | 0.710 |
Why?
|
| Fee-for-Service Plans | 1 | 2020 | 31 | 0.630 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2020 | 61 | 0.620 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2020 | 181 | 0.560 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 261 | 0.530 |
Why?
|
| Hospital Mortality | 1 | 2020 | 485 | 0.520 |
Why?
|
| Pandemics | 2 | 2022 | 882 | 0.510 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2010 | 98 | 0.370 |
Why?
|
| Aorta, Abdominal | 1 | 2010 | 60 | 0.320 |
Why?
|
| Device Removal | 1 | 2011 | 169 | 0.300 |
Why?
|
| Time Factors | 9 | 2020 | 5594 | 0.300 |
Why?
|
| Aorta, Thoracic | 1 | 2010 | 170 | 0.300 |
Why?
|
| Retrospective Studies | 12 | 2023 | 10308 | 0.270 |
Why?
|
| Aged | 13 | 2023 | 20928 | 0.270 |
Why?
|
| Prosthesis Design | 3 | 2023 | 311 | 0.250 |
Why?
|
| Vascular Surgical Procedures | 2 | 2022 | 152 | 0.250 |
Why?
|
| Treatment Outcome | 12 | 2023 | 9228 | 0.250 |
Why?
|
| United States | 4 | 2023 | 7786 | 0.240 |
Why?
|
| Germ Cells | 2 | 2003 | 134 | 0.230 |
Why?
|
| Postoperative Complications | 3 | 2018 | 2603 | 0.230 |
Why?
|
| Mitral Valve | 3 | 2012 | 280 | 0.220 |
Why?
|
| Humans | 24 | 2023 | 96004 | 0.220 |
Why?
|
| Esophageal Perforation | 1 | 2004 | 19 | 0.210 |
Why?
|
| Aged, 80 and over | 7 | 2020 | 7224 | 0.210 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2020 | 42 | 0.200 |
Why?
|
| Infertility, Male | 1 | 2003 | 28 | 0.190 |
Why?
|
| Carotid Arteries | 1 | 2023 | 136 | 0.190 |
Why?
|
| Operating Rooms | 1 | 2023 | 138 | 0.180 |
Why?
|
| Subclavian Artery | 2 | 2011 | 42 | 0.170 |
Why?
|
| Middle Aged | 11 | 2023 | 28300 | 0.170 |
Why?
|
| Diagnosis-Related Groups | 1 | 2020 | 22 | 0.160 |
Why?
|
| Risk Factors | 7 | 2023 | 5992 | 0.160 |
Why?
|
| Academic Medical Centers | 1 | 2023 | 422 | 0.160 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2020 | 66 | 0.160 |
Why?
|
| Hospitals | 1 | 2022 | 329 | 0.150 |
Why?
|
| Emergencies | 1 | 2020 | 123 | 0.150 |
Why?
|
| Female | 13 | 2023 | 49981 | 0.150 |
Why?
|
| Cause of Death | 1 | 2020 | 279 | 0.150 |
Why?
|
| Risk Assessment | 4 | 2020 | 2498 | 0.140 |
Why?
|
| Patient Safety | 1 | 2020 | 225 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 500 | 0.130 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 458 | 0.130 |
Why?
|
| Celiac Artery | 3 | 2015 | 25 | 0.130 |
Why?
|
| Philadelphia | 3 | 2011 | 26 | 0.130 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 140 | 0.130 |
Why?
|
| Vascular System Injuries | 1 | 2017 | 37 | 0.130 |
Why?
|
| Hepatic Artery | 1 | 2017 | 84 | 0.130 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2017 | 111 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2020 | 1541 | 0.120 |
Why?
|
| Male | 14 | 2020 | 45801 | 0.120 |
Why?
|
| Surgeons | 1 | 2021 | 298 | 0.120 |
Why?
|
| Hospitals, University | 3 | 2011 | 199 | 0.120 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 1741 | 0.120 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2011 | 528 | 0.120 |
Why?
|
| Brain Ischemia | 1 | 2020 | 416 | 0.120 |
Why?
|
| Thymectomy | 2 | 2006 | 32 | 0.110 |
Why?
|
| Aortic Aneurysm | 1 | 2015 | 82 | 0.110 |
Why?
|
| Myasthenia Gravis | 2 | 2006 | 83 | 0.100 |
Why?
|
| Catheterization | 1 | 2015 | 237 | 0.100 |
Why?
|
| Models, Cardiovascular | 2 | 2012 | 111 | 0.100 |
Why?
|
| Aortography | 2 | 2010 | 67 | 0.100 |
Why?
|
| Spermatogonia | 2 | 2003 | 13 | 0.100 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 1166 | 0.090 |
Why?
|
| Carotid Artery, Common | 1 | 2011 | 28 | 0.090 |
Why?
|
| Vertebral Artery | 1 | 2011 | 29 | 0.090 |
Why?
|
| Saphenous Vein | 1 | 2011 | 61 | 0.090 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2011 | 364 | 0.090 |
Why?
|
| Length of Stay | 2 | 2015 | 835 | 0.090 |
Why?
|
| Foreign-Body Migration | 1 | 2011 | 34 | 0.080 |
Why?
|
| Endoleak | 1 | 2011 | 42 | 0.080 |
Why?
|
| Aortic Rupture | 1 | 2011 | 58 | 0.080 |
Why?
|
| Prosthesis-Related Infections | 1 | 2011 | 62 | 0.080 |
Why?
|
| Treatment Failure | 1 | 2011 | 297 | 0.080 |
Why?
|
| Survivors | 1 | 2011 | 204 | 0.080 |
Why?
|
| Liver Transplantation | 1 | 2017 | 1201 | 0.080 |
Why?
|
| Heart Valve Diseases | 1 | 2011 | 122 | 0.080 |
Why?
|
| Reoperation | 1 | 2011 | 712 | 0.070 |
Why?
|
| Intensive Care Units | 1 | 2011 | 460 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2011 | 2777 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2010 | 1158 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2010 | 700 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 1319 | 0.050 |
Why?
|
| Alkylating Agents | 1 | 2003 | 32 | 0.050 |
Why?
|
| Busulfan | 1 | 2003 | 42 | 0.050 |
Why?
|
| Renal Artery | 2 | 2015 | 46 | 0.050 |
Why?
|
| Fertility | 1 | 2003 | 119 | 0.050 |
Why?
|
| Testis | 1 | 2003 | 152 | 0.050 |
Why?
|
| Reproduction | 1 | 2003 | 204 | 0.040 |
Why?
|
| Patient Selection | 2 | 2019 | 708 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 1819 | 0.040 |
Why?
|
| New Orleans | 1 | 2021 | 7 | 0.040 |
Why?
|
| Seroepidemiologic Studies | 1 | 2021 | 57 | 0.040 |
Why?
|
| Finite Element Analysis | 2 | 2012 | 80 | 0.040 |
Why?
|
| Esophageal Neoplasms | 1 | 2004 | 345 | 0.040 |
Why?
|
| Haplotypes | 1 | 2003 | 652 | 0.040 |
Why?
|
| Stress, Mechanical | 2 | 2012 | 261 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 365 | 0.040 |
Why?
|
| Data Mining | 1 | 2020 | 44 | 0.040 |
Why?
|
| Stem Cells | 1 | 2003 | 394 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 2885 | 0.040 |
Why?
|
| Natural Language Processing | 1 | 2020 | 42 | 0.040 |
Why?
|
| Leiomyoma | 1 | 2004 | 211 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 348 | 0.040 |
Why?
|
| Health Personnel | 1 | 2021 | 241 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2011 | 890 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2011 | 905 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2019 | 171 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2019 | 216 | 0.030 |
Why?
|
| Louisiana | 1 | 2017 | 18 | 0.030 |
Why?
|
| Logistic Models | 2 | 2011 | 1273 | 0.030 |
Why?
|
| Vascular Patency | 1 | 2017 | 127 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2019 | 348 | 0.030 |
Why?
|
| Angiography | 1 | 2017 | 209 | 0.030 |
Why?
|
| Survival Rate | 2 | 2011 | 1978 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2020 | 373 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 219 | 0.030 |
Why?
|
| Health Status | 1 | 2019 | 386 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 296 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 1561 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2003 | 3491 | 0.030 |
Why?
|
| Pregnancy | 1 | 2003 | 3239 | 0.030 |
Why?
|
| Mesenteric Arteries | 1 | 2015 | 29 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 2015 | 238 | 0.030 |
Why?
|
| Recurrence | 1 | 2017 | 1231 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 823 | 0.020 |
Why?
|
| Adult | 4 | 2019 | 28637 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1983 | 0.020 |
Why?
|
| Prognosis | 1 | 2020 | 3993 | 0.020 |
Why?
|
| Mice | 2 | 2003 | 12537 | 0.020 |
Why?
|
| Ligation | 1 | 2011 | 54 | 0.020 |
Why?
|
| Intracranial Embolism | 1 | 2011 | 30 | 0.020 |
Why?
|
| Constriction | 1 | 2010 | 27 | 0.020 |
Why?
|
| Animals | 3 | 2010 | 28916 | 0.020 |
Why?
|
| Replantation | 1 | 2010 | 36 | 0.020 |
Why?
|
| Sheep | 1 | 2010 | 250 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2012 | 506 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2010 | 99 | 0.020 |
Why?
|
| Monitoring, Intraoperative | 1 | 2011 | 116 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2010 | 281 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2010 | 253 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2012 | 747 | 0.020 |
Why?
|
| Observer Variation | 1 | 2011 | 626 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2010 | 926 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 4690 | 0.020 |
Why?
|
| Child | 1 | 2017 | 7622 | 0.010 |
Why?
|
| Kidney | 1 | 2010 | 1135 | 0.010 |
Why?
|
| Thoracoscopy | 1 | 2004 | 21 | 0.010 |
Why?
|
| Thoracotomy | 1 | 2004 | 68 | 0.010 |
Why?
|
| Esophagus | 1 | 2004 | 113 | 0.010 |
Why?
|
| Lac Operon | 1 | 2003 | 46 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 2003 | 48 | 0.010 |
Why?
|
| Growth Substances | 1 | 2003 | 79 | 0.010 |
Why?
|
| Surgical Stomas | 1 | 2003 | 22 | 0.010 |
Why?
|
| Culture Media | 1 | 2003 | 149 | 0.010 |
Why?
|
| Sternum | 1 | 2002 | 37 | 0.010 |
Why?
|
| Neck | 1 | 2002 | 99 | 0.010 |
Why?
|
| Adolescent | 2 | 2006 | 9880 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2003 | 270 | 0.010 |
Why?
|
| Stem Cell Transplantation | 1 | 2003 | 193 | 0.010 |
Why?
|
| Environment | 1 | 2003 | 233 | 0.010 |
Why?
|
| Remission Induction | 1 | 2002 | 750 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 1618 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2003 | 1645 | 0.010 |
Why?
|
| Cell Line | 1 | 2003 | 2536 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2003 | 2929 | 0.010 |
Why?
|